logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Andrew B Cubitt

This inventor holds 19 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Fluorescent Proteins. Top assignees: University of California, Aurora Biosciences Corporation, Anaptysbio, Inc.. Active years: 1999-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew B Cubitt. Retrieved from https://idiyas.com/inventor/andrew-b-cubitt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 84.2


Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 580(Granted Patents)


Company Filing History:

goldMedal11 out of 16,035 
 
University of California
 patents
silverMedal5 out of 33 
 
Aurora Biosciences Corporation
 patents
bronzeMedal4 out of 23 
 
Anaptysbio, Inc.
 patents
4. 2 out of 145 
 
University of Oregon
 patents
5. 1 out of 1,896 
 
Life Technologies Corporation
 patents
6. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Fluorescent Proteins
Enzyme Detection
Protein Destabilization
Optical Memory Storage
Protein Kinases
Tandem Constructs
Post-Translational Modifications
Long Wavelength Engineering
Assays
Sensors
Libraries
19 patents (USPTO):Explore Patents
1. 9637556 - Methods of generating libraries and uses thereof (2017-05-02),
2. 9260533 - Methods of generating libraries and uses thereof (2016-02-16),
3. 8685897 - Methods of generating libraries and uses thereof (2014-04-01),
4. 8679742 - Method for determining the presence of an enzyme in a sample (2014-03-25),
5. 8603950 - Methods of generating libraries and uses thereof (2013-12-10),
6. 7824850 - Methods of protein destabilization and uses thereof (2010-11-02),
7. 7560287 - Long wavelength engineered fluorescent proteins (2009-07-14),
8. 7262005 - Methods of protein destabilization and uses thereof (2007-08-28),
9. 6780975 - Long wavelength engineered fluorescent proteins (2004-08-24),
10. 6495664 - Fluorescent protein sensors of post-translational modifications (2002-12-17),
11. 6403374 - Long wavelength engineered fluorescent proteins (2002-06-11),
12. 6248550 - Assays for protein kinases using fluorescent protein substrates (2001-06-19),
13. 6124128 - Long wavelength engineered fluorescent proteins (2000-09-26),
14. 6077707 - Long wavelength engineered fluorescent proteins (2000-06-20),
15. 6054321 - Long wavelength engineered fluorescent proteins (2000-04-25),

Title: **Andrew B. Cubitt: A Leader in Antibody Innovation**

Introduction

Andrew B. Cubitt, based in San Diego, CA, is a notable inventor with a remarkable portfolio of 19 patents. His contributions primarily focus on innovative methods for generating humanized antibodies, emphasizing the significance of his research in the biotechnology field.

Latest Patents

Andrew's latest patents include groundbreaking methods related to the generation of humanized antibodies. Specifically, these inventions pertain to the creation of humanized antibody heavy and light chain proteins. The methods involve using cells that express or can be induced to express Activation Induced Cytidine Deaminase (AID), which plays a crucial role in the development of effective therapeutic antibodies.

Career Highlights

Throughout his career, Andrew has made significant strides in the field of biotechnology. He has worked at prominent institutions, including the University of California and Aurora Biosciences Corporation, where he contributed valuable research and fostered innovations that enhance our understanding and utilization of antibodies.

Collaborations

Andrew has collaborated with distinguished colleagues such as Roger Y. Tsien and Roger Heim. These partnerships have likely enriched his research and the advancements of his patented methods, underscoring the importance of teamwork in scientific innovation.

Conclusion

Andrew B. Cubitt's work in developing methods for generating humanized antibodies marks a significant contribution to the field of biotechnology. His inventions and collaborations reflect a commitment to innovation that has the potential to transform therapeutic practices, ensuring his legacy in the scientific community continues to grow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…